Bioventus (BVS) Return on Equity Growth (1y) (2022 - 2026)

Bioventus (BVS) Return on Equity Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE Growth (1y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 0.00
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 0.00
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 0.00
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 0.00
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 0.00
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 0.00
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 0.00
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Bioventus 571.68 Mn 581.20 Mn 90.77 Mn 0.00

Historic Data

Download Data
DateValue
Mar 28, 2026 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jul 1, 2023 -1.00
Apr 1, 2023 0.00
Dec 31, 2022 0.00
Oct 1, 2022 0.00
Jul 2, 2022 0.00
Apr 2, 2022 0.00